DESCRIPTIVE ANALYSIS OF COCAINE USE OF METHADONE PATIENTS

被引:32
作者
KIDORF, M
STITZER, ML
机构
[1] The Johns Hopkins University School of Medicine, Francis Scott Key Medical Center, Baltimore, MD
关键词
COCAINE ABUSE; METHADONE MAINTENANCE; POLYDRUG USE;
D O I
10.1016/0376-8716(93)90091-4
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The increasing prevalence of cocaine use among opioid-dependent participants in methadone treatment has been documented, but there is little information about the quantity-frequency aspects of use. This study examined the cocaine use of methadone maintenance patients to determine amounts and patterns of use as well as use in combination with other drugs. Forty-five cocaine using methadone maintenance patients (78% used i.v.) reported their drug use for each day over the past 7 days after receiving information about their most recent urinalysis test results. Average reported use was 0.23 g cocaine/day on 3.4 days/week. Heroin and cocaine were typically used simultaneously, while only a subset of patients (47%) who used alcohol drank within close proximity to cocaine. Patients who used cocaine with alcohol and/or heroin on the same day (N = 28) reported more cocaine use (M = 1.0 g/week) than patients who used cocaine alone (N = 17; M = 0.49 g/week). The results suggest that methadone maintenance patients generally engage in relatively low dose cocaine use, especially when compared to non opioid dependent patients applying to cocaine treatment programs. The study further shows that patients had clear preferences for drug use combinations, which suggests that interventions for cocaine use might focus on modifying drugs used in combination with cocaine.
引用
收藏
页码:267 / 275
页数:9
相关论文
共 50 条
  • [41] Methadone and nicotine self-administration in humans: a behavioral economic analysis
    Ralph Spiga
    Margaret P. Martinetti
    Richard A. Meisch
    Katherine Cowan
    Steven Hursh
    Psychopharmacology, 2005, 178 : 223 - 231
  • [42] Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment
    Dobler-Mikola, A
    Hättenschwiler, J
    Meili, D
    Beck, T
    Böni, E
    Modestin, J
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2005, 29 (04) : 259 - 265
  • [43] The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence
    Borg, L
    Ho, A
    Wells, A
    Joseph, H
    Appel, P
    Moody, D
    Kreek, MJ
    JOURNAL OF ADDICTIVE DISEASES, 2002, 21 (03) : 13 - 22
  • [44] Characterizing fentanyl use in methadone-maintained clients
    Arfken, Cynthia L.
    Suchanek, Jessica
    Greenwald, Mark K.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2017, 75 : 17 - 21
  • [45] MEASURING HEROIN USE IN METHADONE-MAINTENANCE PROGRAMS
    HOWARD, K
    BELL, J
    CHRISTIE, MJ
    DRUG AND ALCOHOL REVIEW, 1995, 14 (01) : 27 - 34
  • [46] 'Topping up' methadone: An analysis of patterns of heroin use among a treatment sample of Scottish drug users
    Bloor, M.
    McIntosh, J.
    McKeganey, N.
    Robertson, M.
    PUBLIC HEALTH, 2008, 122 (10) : 1013 - 1019
  • [47] Evaluation of poly-drug use in methadone-related fatalities using segmental hair analysis
    Nielsen, Marie Katrine Klose
    Johansen, Sys Stybe
    Linnet, Kristian
    FORENSIC SCIENCE INTERNATIONAL, 2015, 248 : 134 - 139
  • [48] The impact of benzodiazepine use on methadone maintenance treatment outcomes
    Brands, Bruna
    Blake, Joan
    Marsh, David C.
    Sproule, Beth
    Jeyapalan, Renuka
    Li, Selina
    JOURNAL OF ADDICTIVE DISEASES, 2008, 27 (03) : 37 - 48
  • [49] Substance Use and Response to Psychiatric Treatment in Methadone-Treated Outpatients with Comorbid Psychiatric Disorder
    Kidorf, Michael
    King, Van L.
    Peirce, Jessica
    Gandotra, Neeraj
    Ghazarian, Sharon
    Brooner, Robert K.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2015, 51 : 64 - 69
  • [50] PSYCHOPHYSIOLOGICAL REACTIONS IN METHADONE-MAINTENANCE PATIENTS DO NOT CORRELATE WITH METHADONE PLASMA-LEVELS
    LOIMER, N
    SCHMID, R
    GRUNBERGER, J
    JAGSCH, R
    LINZMAYER, L
    PRESSLICH, O
    PSYCHOPHARMACOLOGY, 1991, 103 (04) : 538 - 540